Brian R Slawski
Examiner (ID: 259, Phone: (571)270-3855 , Office: P/1745 )
Most Active Art Unit | 1745 |
Art Unit(s) | 1791, 1745 |
Total Applications | 835 |
Issued Applications | 640 |
Pending Applications | 49 |
Abandoned Applications | 146 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 18754158
[patent_doc_number] => 20230357542
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-09
[patent_title] => CELLULOSE PROCESSING
[patent_app_type] => utility
[patent_app_number] => 18/220685
[patent_app_country] => US
[patent_app_date] => 2023-07-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13034
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 87
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18220685
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/220685 | CELLULOSE PROCESSING | Jul 10, 2023 | Pending |
Array
(
[id] => 18717911
[patent_doc_number] => 11795242
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2023-10-24
[patent_title] => Method for adjusting porous structure and texture of freeze-dried pectin aerogel
[patent_app_type] => utility
[patent_app_number] => 18/336627
[patent_app_country] => US
[patent_app_date] => 2023-06-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 4
[patent_no_of_words] => 2886
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 102
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18336627
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/336627 | Method for adjusting porous structure and texture of freeze-dried pectin aerogel | Jun 15, 2023 | Issued |
Array
(
[id] => 18737797
[patent_doc_number] => 20230346692
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-02
[patent_title] => METHODS FOR REVERSIBLE MALE BIRTH CONTROL
[patent_app_type] => utility
[patent_app_number] => 18/309554
[patent_app_country] => US
[patent_app_date] => 2023-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9108
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18309554
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/309554 | METHODS FOR REVERSIBLE MALE BIRTH CONTROL | Apr 27, 2023 | Pending |
Array
(
[id] => 18565602
[patent_doc_number] => 20230255929
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-17
[patent_title] => CDC7 KINASE INHIBITORS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/138351
[patent_app_country] => US
[patent_app_date] => 2023-04-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26019
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 180
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18138351
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/138351 | CDC7 KINASE INHIBITORS AND USES THEREOF | Apr 23, 2023 | Pending |
Array
(
[id] => 18806882
[patent_doc_number] => 20230381215
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-30
[patent_title] => NOVEL COMBINATION TREATMENT FOR ACUTE MYELOID LEUKEMIA (AML)
[patent_app_type] => utility
[patent_app_number] => 18/130016
[patent_app_country] => US
[patent_app_date] => 2023-04-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6003
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18130016
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/130016 | NOVEL COMBINATION TREATMENT FOR ACUTE MYELOID LEUKEMIA (AML) | Apr 2, 2023 | Pending |
Array
(
[id] => 18739732
[patent_doc_number] => 20230348699
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-02
[patent_title] => HYDROPHOBICALLY MODIFIED CHITOSAN COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 18/129239
[patent_app_country] => US
[patent_app_date] => 2023-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6556
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18129239
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/129239 | HYDROPHOBICALLY MODIFIED CHITOSAN COMPOSITIONS | Mar 30, 2023 | Pending |
Array
(
[id] => 19225441
[patent_doc_number] => 12005071
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-06-11
[patent_title] => Injectable antibiotic formulations and use thereof
[patent_app_type] => utility
[patent_app_number] => 18/123811
[patent_app_country] => US
[patent_app_date] => 2023-03-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3919
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18123811
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/123811 | Injectable antibiotic formulations and use thereof | Mar 19, 2023 | Issued |
Array
(
[id] => 18510091
[patent_doc_number] => 20230226190
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-20
[patent_title] => COMPOSITIONS AND METHODS FOR DELIVERING AN AGENT TO A WOUND
[patent_app_type] => utility
[patent_app_number] => 18/102123
[patent_app_country] => US
[patent_app_date] => 2023-01-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22310
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -76
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18102123
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/102123 | COMPOSITIONS AND METHODS FOR DELIVERING AN AGENT TO A WOUND | Jan 26, 2023 | Pending |
Array
(
[id] => 18595977
[patent_doc_number] => 20230270767
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-31
[patent_title] => INHIBITORS OF ENPP1 AND METHODS OF USING SAME
[patent_app_type] => utility
[patent_app_number] => 18/100342
[patent_app_country] => US
[patent_app_date] => 2023-01-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12595
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18100342
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/100342 | INHIBITORS OF ENPP1 AND METHODS OF USING SAME | Jan 22, 2023 | Pending |
Array
(
[id] => 18647014
[patent_doc_number] => 20230292781
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-21
[patent_title] => METHODS OF MAINTAINING OR INCREASING GROWTH OR COGNITIVE DEVELOPMENT
[patent_app_type] => utility
[patent_app_number] => 18/084954
[patent_app_country] => US
[patent_app_date] => 2022-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13843
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18084954
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/084954 | METHODS OF MAINTAINING OR INCREASING GROWTH OR COGNITIVE DEVELOPMENT | Dec 19, 2022 | Pending |
Array
(
[id] => 18792629
[patent_doc_number] => 11826362
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-11-28
[patent_title] => Composition for enhancing mitochondrial function
[patent_app_type] => utility
[patent_app_number] => 18/051460
[patent_app_country] => US
[patent_app_date] => 2022-10-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8969
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 111
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18051460
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/051460 | Composition for enhancing mitochondrial function | Oct 30, 2022 | Issued |
Array
(
[id] => 18324536
[patent_doc_number] => 20230122664
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-20
[patent_title] => COMPOSITIONS COMPRISING 2'-DEOXYCYTIDINE ANALOGS AND USE THEREOF FOR THE TREATMENT OF SICKLE CELL DISEASE, THALASSEMIA, AND CANCERS
[patent_app_type] => utility
[patent_app_number] => 17/969192
[patent_app_country] => US
[patent_app_date] => 2022-10-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 38109
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17969192
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/969192 | Compositions comprising 2'-deoxycytidine analogs and use thereof for the treatment of sickle cell disease, thalassemia, and cancers | Oct 18, 2022 | Issued |
Array
(
[id] => 18361232
[patent_doc_number] => 20230142823
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-11
[patent_title] => MULTI-TARGET ANTIMICROBIAL COMPOSITIONS COMPRISING CHITOSAN
[patent_app_type] => utility
[patent_app_number] => 17/940420
[patent_app_country] => US
[patent_app_date] => 2022-09-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6583
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17940420
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/940420 | Multi-target antimicrobial compositions comprising chitosan | Sep 7, 2022 | Issued |
Array
(
[id] => 19372411
[patent_doc_number] => 12063949
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-08-20
[patent_title] => Mixture of HMOs
[patent_app_type] => utility
[patent_app_number] => 17/929905
[patent_app_country] => US
[patent_app_date] => 2022-09-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8247
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17929905
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/929905 | Mixture of HMOs | Sep 5, 2022 | Issued |
Array
(
[id] => 18034759
[patent_doc_number] => 20220378974
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-01
[patent_title] => HEMOSTATIC MATERIAL AND WOUND DRESSING CONTAINING SAME
[patent_app_type] => utility
[patent_app_number] => 17/818551
[patent_app_country] => US
[patent_app_date] => 2022-08-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4368
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17818551
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/818551 | Hemostatic material and wound dressing containing same | Aug 8, 2022 | Issued |
Array
(
[id] => 18434329
[patent_doc_number] => 20230181623
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-15
[patent_title] => COMPOSITIONS AND METHODS OF USE FOR WOUND HEALING
[patent_app_type] => utility
[patent_app_number] => 17/869113
[patent_app_country] => US
[patent_app_date] => 2022-07-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19559
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17869113
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/869113 | COMPOSITIONS AND METHODS OF USE FOR WOUND HEALING | Jul 19, 2022 | Pending |
Array
(
[id] => 18468804
[patent_doc_number] => 20230203086
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-29
[patent_title] => RIBONUCLEIC ACID PURIFICATION
[patent_app_type] => utility
[patent_app_number] => 17/854187
[patent_app_country] => US
[patent_app_date] => 2022-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11157
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17854187
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/854187 | Ribonucleic acid purification | Jun 29, 2022 | Issued |
Array
(
[id] => 17928348
[patent_doc_number] => 20220323473
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-13
[patent_title] => METHODS OF TREATING DISEASES
[patent_app_type] => utility
[patent_app_number] => 17/809618
[patent_app_country] => US
[patent_app_date] => 2022-06-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11079
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -3
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17809618
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/809618 | METHODS OF TREATING DISEASES | Jun 28, 2022 | Abandoned |
Array
(
[id] => 18829530
[patent_doc_number] => 20230398054
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-14
[patent_title] => Composition For Controlled Release Of Actives
[patent_app_type] => utility
[patent_app_number] => 17/806294
[patent_app_country] => US
[patent_app_date] => 2022-06-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3372
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 108
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17806294
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/806294 | Composition For Controlled Release Of Actives | Jun 9, 2022 | Pending |
Array
(
[id] => 18144060
[patent_doc_number] => 20230017911
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-19
[patent_title] => TREATMENT OF SLEEP-WAKE DISORDERS AND NEURODEGENERATIVE DISEASE COMPRISING MODIFIED RESISTANT MALTODEXTRIN
[patent_app_type] => utility
[patent_app_number] => 17/828758
[patent_app_country] => US
[patent_app_date] => 2022-05-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6758
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17828758
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/828758 | TREATMENT OF SLEEP-WAKE DISORDERS AND NEURODEGENERATIVE DISEASE COMPRISING MODIFIED RESISTANT MALTODEXTRIN | May 30, 2022 | Pending |